Skip to main content

Table 1 Outcomes of LVAD implantation in patients with left ventricular non-compaction

From: Left ventricular non-compaction cardiomyopathy and left ventricular assist device: a word of caution

 

No.

Patients

Device

Duration of support

Complications

Outcome

Maile et al., 2004 [4]

1

Male, 51 years

DeBakey MicroMed LVAD

2.5 months

None

Successfully bridged to transplantation

Ivan et al., 2005 [6]

2

Male, 21 years

Jarvik biventricular assist device

Not indicated

Not indicated

Death before transplantation

  

Male, 37 years

Thoratec RVAD and

HeartMate LVAD

Not indicated

Not indicated

Death after transplantation

Nathan et al., 2010 [9]

1

Male, 14 years

Abiomed, biventricular assist device

5 days

None

Successfully bridged to transplantation

Ninios et al., 2010 [5]

1

Male, 28 years

Jarvik 2000 LV

3 years

Recurrent thrombosis with successful intravenous lysis

Patient on LVAD support at the date of publication

Hanke et al., 2012 [10]

1

Male, 12 months

Berlin Heart, Excor, biventricular assist device

24 days

Pulmonary haemorrhage requiring use of a membrane oxygenator, thrombosis requiring replacement of the LVAD

Successfully bridged to transplantation

Siehr et al., 2013 [11]

1

Male, 6 weeks

Berlin Heart, Excor, LVAD

56 days

Embolic cerebrovascular accident, 2 pump exchanges due to clot formation

Successfully bridged to transplantation

Uribarri et al., 2015 [7]

5

4 males (23, 25, 43,54 years)

1 female (24 years)

3 HVAD

2 HeartMate II

Mean follow up period 86.5 weeks, range 40–194 weeks

4 cases of pump thrombosis in 3 of 5 patients

2 deaths, 3 patients on LVAD support at the date of publication